CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Probiotic study for diabetes and COPD halted early
Disease control TerminatedThis study tested whether taking probiotics alongside standard treatment could lower blood sugar and improve lung function in people with both type 2 diabetes and chronic obstructive pulmonary disease (COPD). The trial planned to enroll 30 adults aged 50-85, but was terminated ea…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
COPD-Linked lung pressure study halted early
Disease control TerminatedThis study looked at the safety of continuing an inhaled medication called treprostinil in people who have both COPD and high blood pressure in the lungs (pulmonary hypertension). It included 41 adults who had already completed a previous study. The goal was to see if long-term u…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:32 UTC
-
New COPD inhaler combo aims to cut Flare-Ups in High-Risk patients
Disease control TerminatedThis study tested whether adding an experimental inhaler (CHF6001) to standard triple therapy could reduce flare-ups in people with severe COPD and chronic bronchitis. About 4,000 adults aged 40 and older who were current or former smokers and had at least one flare-up in the pas…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
New COPD drug trial halted: did it fail to prevent Flare-Ups?
Disease control TerminatedThis study tested two doses of an inhaled drug called CHF6001 (Tanimilast) in people with COPD and chronic bronchitis who were already on standard triple therapy. The goal was to see if adding this drug could reduce moderate or severe flare-ups over a year. The trial was stopped …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:28 UTC
-
New COPD inhaler shows promise in early trial
Disease control TerminatedThis study tested an experimental inhaled drug called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The goal was to see if it improves lung function compared to an active control. About 200 adults aged 40 and older with a history of COPD …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Can rehab at home match clinic care for COPD?
Disease control TerminatedThis study looked at whether doing breathing exercises at home works as well as doing them at a clinic for people with chronic obstructive pulmonary disease (COPD). The trial involved 188 adults with moderate to severe COPD. Researchers measured exercise ability, breathing diffic…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Mucus-Targeting inhaler tested for lung disease – study stopped early
Disease control TerminatedThis study tested an inhaled drug called ARO-MUC5AC in healthy people and those with asthma or COPD. The goal was to see if it was safe and could improve lung function by reducing mucus. The study was terminated early, so results are limited.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Bringing comfort home: palliative care study aims to ease suffering
Symptom relief TerminatedThis study tested whether providing palliative care at home, through primary care clinics, helps seriously ill patients with cancer, heart failure, or COPD feel better. About 35 patients were enrolled, and researchers measured symptoms, anxiety, and depression. The goal was to im…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC
-
AI listens to lungs: new study analyzes breathing sounds in chronic lung diseases
Knowledge-focused TerminatedThis study tested whether an electronic stethoscope combined with artificial intelligence could detect and classify abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers recorded lung sounds during routine checkups and used AI to identify p…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC